Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-254539
Filing Date
2017-08-10
Accepted
2017-08-10 16:32:58
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d592407d10q.htm 10-Q 363137
2 EX-31.1 d592407dex311.htm EX-31.1 6638
3 EX-31.2 d592407dex312.htm EX-31.2 6753
4 EX-32.1 d592407dex321.htm EX-32.1 4531
  Complete submission text file 0001193125-17-254539.txt   3405083

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zsan-20170630.xml EX-101.INS 672255
6 XBRL TAXONOMY EXTENSION SCHEMA zsan-20170630.xsd EX-101.SCH 41549
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zsan-20170630_cal.xml EX-101.CAL 57612
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zsan-20170630_def.xml EX-101.DEF 150281
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20170630_lab.xml EX-101.LAB 369647
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20170630_pre.xml EX-101.PRE 249807
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

EIN.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 171021864
SIC: 2834 Pharmaceutical Preparations